Skip to main content
. 2018 Dec 12;31(2):157–160. doi: 10.1016/j.joco.2018.11.006

Table 2.

The central macular thickness (CMT) of patients at different evaluation times.

Variables Before One month Three months P valuea
CMT Laser + IVB 513 ± 126.29 454.62 ± 94.79 408.1 ± 95.28 <0.001
IVB 494.38 ± 130.7 492.14 ± 130.27 502.38 ± 145.88 0.64
P-valueb 0.64 0.30 0.02

CMT: Central macular thickness, IVB: Intravitreal bevacizumab.

a

Repeated measure ANOVA.

b

Independent t-test.